These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 10990367)

  • 1. Reducing cardiovascular morbidity and mortality from hypertension in end-stage renal disease.
    Picton ML; Foley RN
    Curr Opin Nephrol Hypertens; 2000 Sep; 9(5):497-500. PubMed ID: 10990367
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effects of various antihypertensive agents on cardiovascular risk factors in patients with renal failure.
    Zarama M; Raij L
    Am J Kidney Dis; 1993 May; 21(5 Suppl 2):100-7. PubMed ID: 8494007
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cardiovascular risk in patients with early renal insufficiency: implications for the use of ACE inhibitors.
    Mann JF; Gerstein HC; Pogue J; Lonn E; Yusuf S
    Am J Cardiovasc Drugs; 2002; 2(3):157-62. PubMed ID: 14727978
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Influence of a supplementation with vitamins on cardiovascular morbidity and mortality in patients with end-stage renal disease: design and baseline data of a randomized clinical trial.
    Heinz J; Domröse U; Luley C; Westphal S; Kropf S; Neumann KH; Dierkes J
    Clin Nephrol; 2009 Mar; 71(3):363-5. PubMed ID: 19281755
    [No Abstract]   [Full Text] [Related]  

  • 5. [Cardioprotection: an essential component for predialysis chronic renal failure treatment].
    Jungers P; Qualim Z; Nguyen-Khoa T; Massy Z; London G
    Nephrologie; 2003; 24(2):79-88. PubMed ID: 12723513
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Do potassium deficient diets and K+ removal by dialysis contribute to the cardiovascular morbidity and mortality of patients with end stage renal disease?
    Dolson GM
    Int J Artif Organs; 1997 Mar; 20(3):134-5. PubMed ID: 9151147
    [No Abstract]   [Full Text] [Related]  

  • 7. Are antihypertensive drugs used to maximally reduce cardiovascular risk in dialysis patients?
    Garg J; Bakris GL
    Am J Kidney Dis; 2003 Dec; 42(6):1301-4. PubMed ID: 14655205
    [No Abstract]   [Full Text] [Related]  

  • 8. Renal outcomes with different fixed-dose combination therapies in patients with hypertension at high risk for cardiovascular events (ACCOMPLISH): a prespecified secondary analysis of a randomised controlled trial.
    Bakris GL; Sarafidis PA; Weir MR; Dahlöf B; Pitt B; Jamerson K; Velazquez EJ; Staikos-Byrne L; Kelly RY; Shi V; Chiang YT; Weber MA;
    Lancet; 2010 Apr; 375(9721):1173-81. PubMed ID: 20170948
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The careful correction of renal insufficiency abnormalities: early is good.
    Zucchelli P
    Nephrol Dial Transplant; 2000; 15 Suppl 2():2-6. PubMed ID: 11051030
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Haemodialysis and hypertension].
    van der Giet M; Zidek W
    Dtsch Med Wochenschr; 2006 Nov; 131(46):2605-9. PubMed ID: 17096308
    [No Abstract]   [Full Text] [Related]  

  • 11. Dialysis in 2011: Can cardiovascular risk in dialysis patients be decreased?
    Stenvinkel P; Bárány P
    Nat Rev Nephrol; 2011 Dec; 8(2):72-4. PubMed ID: 22158474
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anaemia, renal insufficiency and cardiovascular outcome.
    Hegarty J; Foley RN
    Nephrol Dial Transplant; 2001; 16 Suppl 1():102-4. PubMed ID: 11369834
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chronic kidney disease as a cardiovascular risk factor.
    Best PJ; Holmes DR
    Am Heart J; 2003 Mar; 145(3):383-6. PubMed ID: 12660658
    [No Abstract]   [Full Text] [Related]  

  • 14. [Hypertension, dyslipidemia and cardiovascular risk in chronic renal disease].
    Ravera M; Paoletti E
    Ital Heart J Suppl; 2004 Jun; 5(6):436-44. PubMed ID: 15471148
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cardiovascular mortality and morbidity in dialysis patients.
    Eknoyan G
    Miner Electrolyte Metab; 1999; 25(1-2):100-4. PubMed ID: 10207269
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Arterial hypertension and mortality in dialysis patients. RPDT Working Group.
    Quarello F; Piccoli GB; Magistroni P; Cavalli PL; Cavagnino A; Salomone M; Boero R; Funaro L; Marciello A; Ferro M; Piccoli G
    Contrib Nephrol; 1996; 119():141-6. PubMed ID: 8783605
    [No Abstract]   [Full Text] [Related]  

  • 17. How can the cardiac death rate be reduced in dialysis patients?
    Avram MM
    Semin Dial; 2002; 15(1):26-9. PubMed ID: 11874588
    [No Abstract]   [Full Text] [Related]  

  • 18. [Cardiovascular risk in patients with chronic renal failure. Patients in renal replacement therapy].
    Cases A; Vera M; López Gómez JM
    Nefrologia; 2002; 22 Suppl 1():68-74. PubMed ID: 11987673
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The relevance of a decline in renal function for risk of renal failure, cardiovascular events and all-cause mortality].
    Bots ML; Blankestijn PJ
    Ned Tijdschr Geneeskd; 2015; 159():A8106. PubMed ID: 26374717
    [TBL] [Abstract][Full Text] [Related]  

  • 20. ACE inhibitors and survival of hemodialysis patients.
    Efrati S; Zaidenstein R; Dishy V; Beberashvili I; Sharist M; Averbukh Z; Golik A; Weissgarten J
    Am J Kidney Dis; 2002 Nov; 40(5):1023-9. PubMed ID: 12407648
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.